Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Unicycive Therapeutics, Inc. Common Stock (UNCY)

Pharmaceutical Preparations

https://www.unicycive.com

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

4300 EL CAMINO REAL, SUITE 210
LOS ALTOS, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/13/2021

Market Cap

25,610,111

Shares Outstanding

34,750,000

Weighted SO

34,754,401

Total Employees

N/A

Upcoming Earnings

08/12/2024

Beta

2.3740

Last Div

0.0000

Range

0.202-1.818

Chg

-0.0011

Avg Vol

1970769

Mkt Cap

25610111

Exch

NASDAQ

Country

US

Phone

650 351 4495

DCF Diff

-0.0926

DCF

0.3926

Div Yield

0.0000

P/S

-94.5023

EV Multiple

-1.0759

P/FV

-0.7634

Div Yield %

0.0000

P/E

-0.3876

PEG

0.1163

Payout

-0.0742

Current Ratio

3.3665

Quick Ratio

3.3665

Cash Ratio

3.1927

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1207.3708

CCC

-1207.3708

Gross Margin

2.6421

Op Margin

106.4797

Pretax Margin

86.0185

Net Margin

107.8819

Eff Tax Rate

0.1906

ROA

-0.6540

ROE

2.9474

ROCE

-0.9127

NI/EBT

1.2542

EBT/EBIT

0.8078

EBIT/Rev

106.4797

Debt Ratio

1.0413

D/E

-3.1353

LT Debt/Cap

1.4737

Total Debt/Cap

1.4683

Int Coverage

-5771.2000

CF/Debt

-0.4648

Equity Multi

-3.0110

Rec Turnover

0.0000

Pay Turnover

0.3023

Inv Turnover

0.0000

FA Turnover

-0.4189

Asset Turnover

-0.0061

OCF/Share

-0.5706

FCF/Share

-0.5713

Cash/Share

1.1019

OCF/Sales

79.8376

FCF/OCF

1.0012

CF Coverage

-0.4648

ST Coverage

-60.1000

CapEx Coverage

-832.1538

Div&CapEx Cov

-9.8525

P/BV

-0.7634

P/B

-0.7634

P/S

-94.5023

P/E

-0.3876

P/FCF

-1.1823

P/OCF

-0.5238

P/CF

-0.5238

PEG

0.1163

P/S

-94.5023

EV Multiple

-1.0759

P/FV

-0.7634

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation